Archaeological signatures of landscape and settlement change on the Isle of Harris

Between 2004 and 2011, a programme of archaeological investigation by the University of Birmingham on the Isle of Harris, a distinctive island forming part of the Western Isles of Scotland, has allowed the archaeological remains of this enigmatic place to be further characterised and understood. Despite intensive archaeological interest in the archipelago for a number of decades, the Isle of Harris has been overlooked and only now are we beginning to identify the archaeological resource and make comparisons to the wealth of published data from islands such as the Uists, Barra and Lewis. This paper highlights some generic overall patterns of archaeological signatures on the Isle which has been identified through a range of archaeological methods including field walking, intrusive excavation, aerial reconnaissance, geophysical and topographical survey, and documentary research. Several key case studies will be introduced including upland shieling complexes and mulitperiod settlement sites on the west coast machair systems. The purpose of the paper is not to present a gazetteer of the results of the work to date, but to highlight some of the key findings with a view to demonstrating that the Isle of Harris is directly comparable with the archaeologically rich landscapes of the other islands

Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy

The identification of patients who will respond to anti-tumor necrosis factor alpha (anti-TNF-α) therapy will improve the efficacy, safety, and economic impact of these agents. We investigated whether killer cell immunoglobulin-like receptor (KIR) genes are related to response to anti-TNF-α therapy in patients with rheumatoid arthritis (RA). Sixty-four RA patients and 100 healthy controls were genotyped for 16 KIR genes and human leukocyte antigen-C (HLA-C) group 1/2 using polymerase chain reaction sequence-specific oligonucleotide probes (PCR-SSOP). Each patient received anti-TNF-α therapy (adalimumab, etanercept, or infliximab), and clinical responses were evaluated after 3 months using the disease activity score in 28 joints (DAS28). We investigated the correlations between the carriership of KIR genes, HLA-C group 1/2 genes, and clinical data with response to therapy. Patients responding to therapy showed a significantly higher frequency of KIR2DS2/KIR2DL2 (67.7% R vs. 33.3% NR; P = 0.012). A positive clinical outcome was associated with an activating KIR–HLA genotype; KIR2DS2(+)HLA-C group 1/2 homozygous. Inversely, non-response was associated with the relatively inhibitory KIR2DS2(–)HLA-C group 1/2 heterozygous genotype. The KIR and HLA-C genotype of an RA patient may provide predictive information for response to anti-TNF-α therapy

Exploring the concept of patient centred communication for the pharmacy practice

Background Patient centred communication can improve pharmaceutical care, but is not well described for pharmacists. Aim of the review To provide a comprehensive and accessible overview of the concept of patient centred communication for the pharmacy practice. Method A scoping review and thematic analysis was undertaken to synthesize the extracted data and present it in a model. Results Literature search and selection resulted in eighteen articles. Thematic analysis of the extracted data led to five categories regarding patient centred communication. Two categories refer to phases of a pharmaceutical consultation: (1) shared problem defining and (2) shared decision making; three refer to underlying concepts and assumptions about patient centredness regarding (3) the patient, (4) the pharmacist and (5) the therapeutic relation. The categories were modelled in the so called Utrecht’s Model for Patient centred communication in the Pharmacy. Conclusion Although there might be barriers to implement patient centred communication in the pharmacy, the concept of patient centred communication as described in the literature is relevant for the pharmacy practice

Determining the future for irradiated graphite disposal

In recent years, proposals have been made for the longterm treatment of radioactive graphite waste which have ranged from sea dumping through incineration to land-based disposal, sometimes preceded by a variable period of 'safe storage' within the original reactor containment. Nuclear regulators are challenging the proposed length of 'safe storage' on the basis that essential knowledge may be lost. More recently, political constraints have further complicated the issue by eliminating disposal at sea and imposing a 'near-zero release' philosophy, while public opinion is opposed to land-based disposal and has induced a continual drive towards minimizing radioactivity release to the environment from disposal. This paper proposes that, despite various international agreements, it is time to review technically all options for disposal of irradiated graphite waste as a framework for the eventual decisionmaking process. It is recognized that the socio-economic and political pressures are high and therefore, given that all currently identified options satisfy the present safety limits, the need to minimize the objective risk is shown to be a minor need in comparison to the public's want of demonstrable control, responsiveness and ability to reverse/change the disposal options in the future. Further, it is shown that the eventual decision-making process for a post-dismantling option for graphite waste must optimize the beneficial attributes of subjective risk experienced by the general public. In addition, in advocating and preferred option to the general public, it is recommended that the industry should communicate at a level commensurate with the public understanding and initiate a process of facilitation which enables the public to arrive at their own solution and constituting a social exchange. Otherwise it is concluded that if the indecision over disposal options is allowed to continue then, by default, graphite will remain in long-term supervised storage

Sr isotope evidence for population movement within the Hebridean Norse community of NW Scotland

The excavation at Cnip, Isle of Lewis, Scotland, of the largest, and only known family cemetery from the early Norse period in the Hebrides, provided a unique opportunity to use Sr isotope analysis to examine the origins of people who may have been Norwegian Vikings. Sr isotope analysis permits direct investigation of a person's place of origin rather than indirectly through acquired cultural and artefactual affiliations. Sr isotope data suggest that the Norse group at Cnip was of mixed origins. The majority were consistent with indigenous origins but two individuals, of middle-age and different sex, were immigrants. They were, however, not from Norway but were raised separately, most probably on Tertiary volcanic rocks (e.g. the Inner Hebrides or NE Ireland) or, for the female, on marine carbonate rocks